Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Yue, Yuan ^a   Shao, Yuan ^a   Luo, Qing ^b   Shi, Lei ^a   Wang, Zuoren ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b 417 Hospital of Nuclear Industry   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; MESSENGER RNA; SMALL INTERFERING RNA; UVOMORULIN; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; CADHERIN; MEMBRANE PROTEIN; SECRETASE;

ARTICLE; BASEMENT MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; METASTASIS; PROTEIN EXPRESSION; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; PATHOLOGY; RETRACTED ARTICLE; CELL STRAIN HEPG2; DRUG ANTAGONISM;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, SMALL INTERFERING;

EID: 84881506124     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/434561     Document Type: Article

References (23)

1. Zheng X., Gai X., Wu Z., Liu Q., Yao Y., Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT. Oncology Reports 2013 29 5 1811 1818
2. Wu D., Ding J., Wang L., Pan H., Zhou Z., Zhou J., Qu P., microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer. Oncology Letters 2013 5 3 829 834
3. Wang Z. G., Jia M. K., Cao H., Bian P., Fang X. D., Knockdown of Coronin-1C disrupts Rac1 activation and impairs tumorigenic potential in hepatocellular carcinoma cells. Oncology Reports 2013 29 3 1066 1072
4. Hoenicke L., Zender L., Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies. Carcinogenesis 2012 33 6 1123 1126 10.1093/carcin/bgs124
5. Canning C., O'Brien M., Hegarty J., O'Farrelly C., Liver immunity and tumour surveillance. Immunology Letters 2006 107 2 83 88 2-s2.0-33751180964 10.1016/j.imlet.2006.07.002 (Pubitemid 44779810)
6. Smith H. A., Kang Y., The metastasis-promoting roles of tumor-associated immune cells. Journal of Molecular Medicine 2013 91 4 411 429 10.1007/s00109-013-1021-5
7. Gil M., Seshadri M., Komorowski M. P., Abrams S. I., Kozbor D., Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases. Proceedings of the National Academy of Sciences of the United States of America 2013 110 14 E1291 E1300
8. Zhao G., Huang Z. M., Kong Y. L., Wen D. Q., Li Y., Ren L., Zhang H. Y., Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma. World Journal of Surgical Oncology 2013 11 1 74 10.1186/1477-7819-11-74
9. Schneider M., Hadaschik B., Hallscheidt P., Manual repositioning of intra-atrial kidney cancer tumor thrombus: a technique reducing the need for cardiopulmonary bypass. Urology 2013 81 4 909 914 10.1016/j.urology.2012.10.064
10. Man Y. G., Stojadinovic A., Mason J., Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. Journal of Cancer 2013 4 1 84 95 10.7150/jca.5482
11. Ramasubba C., Cohen S. P., Cooled sacroiliac radiofrequency denervation for the treatment of pain secondary to tumor infiltration: a case-based focused literature review. Pain Physician 2013 16 1 1 8
12. Umansky V., Sevko A., Tumor microenvironment and myeloid-derived Suppressor cells. Cancer Microenviron 2012 10.1007/s12307-012-0126-7
13. Canel M., Serrels A., Frame M. C., Brunton V. G., E-cadherin-integrin crosstalk in cancer invasion and metastasis. Journal of Cell Science 2013 126 2 393 401
14. Griffin J. R., Wriston C. C., Peters M. S., Lehman J. S., Decreased expression of intercellular adhesion molecules in acantholytic squamous cell carcinoma compared with invasive well-differentiated squamous cell carcinoma of the skin. American Journal of Clinical Pathology 2013 139 4 442 447 10.1309/AJCPTN4BNJYIRUWO
15. Boterberg T., Vennekens K. M., Thienpont M., Mareel M. M., Bracke M. E., Internalization of the E-cadherin/catenin complex and scattering of human mammary carcinoma cells MCF-7/AZ after treatment with conditioned medium from human skin squamous carcinoma cells COLO 16. Cell Adhesion and Communication 2000 7 4 299 310 2-s2.0-0033980552 (Pubitemid 30103498)
16. Luca A. C., Mersch S., Deenen R., Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 2013 8 3 e59689
17. Przemyslaw L., Boguslaw H. A., Elzbieta S., Malgorzata S. M., ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis. BMB Reports 2013 46 3 139 150 10.5483/BMBRep.2013.46.3.176
18. Cochet M., Donneger R., Cassier E., 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10. ACS Chemical Neuroscience 2013 4 1 130 140 10.1021/cn300095t
19. Schirrmeister W., Gnad T., Wex T., Higashiyama S., Wolke C., Naumann M., Lendeckel U., Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection. Experimental Cell Research 2009 315 20 3500 3508 2-s2.0-70449532978 10.1016/j.yexcr.2009.07.029
20. Dittmer A., Hohlfeld K., Lützkendorf J., Müller L. P., Dittmer J., Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10. Cellular and Molecular Life Sciences 2009 66 18 3053 3065 2-s2.0-69949141694 10.1007/s00018-009-0089-0
21. Soundararajan R., Sayat R., Robertson G. S., Marignani P. A., Triptolide: an inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells. Cancer Biology and Therapy 2009 8 21 2054 2062 2-s2.0-73549100626
22. Erin N., Zhao W., Bylander J., Chase G., Clawson G., Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells. Breast Cancer Research and Treatment 2006 99 3 351 364 2-s2.0-33748337099 10.1007/s10549-006-9219-7 (Pubitemid 44337928)
23. Cheng G. Z., Chan J., Wang Q., Zhang W., Sun C. D., Wang L.-H., Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Research 2007 67 5 1979 1987 2-s2.0-33947192053 10.1158/0008-5472.CAN-06-1479 (Pubitemid 46424214)